Scientific Advisory Board

Norman Baylor

Dr. Norman W. Baylor is currently Vice Chair of the Board of Trustees at the Sabin Vaccine Institute in Washington, DC. He is also the Editor-in-Chief of Biologicals, a journal of the International Alliance for Biological Standardization (IABS).  Dr. Baylor was formerly the Director of the Office of Vaccines Research and Review (OVRR) in the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research. He has evaluated and/or facilitated the development and licensure of numerous vaccines and related products during his 20-year career at FDA. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, the US Department of Health and Human Services National Vaccine Advisory Committee, the Advisory Commission on Childhood Vaccines, and a member of the NIH NIAID Council. Dr. Baylor served as an expert advisor to the World Health Organization on several global vaccine initiatives. 

Shiranee Sriskandan

Professor Shiranee Sriskandan is a Professor of Infectious Diseases and a Clinical Infectious Diseases Consultant at Imperial College London. She leads the Gram Positive Pathogenesis research group and is Co-Director of the Centre for Bacteria Resistance Biology. Her research focuses on understanding the mechanisms by which Streptococcus pyogenes causes severe disease, spanning pathogen biology, transmission, and host immune responses. She has a particular interest in streptococcal vaccine development and the impact of bacterial evolution on vaccine targets.

Terry Nolan 

Professor Terry Nolan is the Redmond Barry Distinguished Professor Emeritus at the University of Melbourne and serves as Chair of our Scientific Advisory Board (SAB). He is the former Head of the Vaccine and Immunisation Research Group (VIRGo) at the Peter Doherty Institute for Infection and Immunity and the Murdoch Children's Research Institute, and was the Foundation Head of the Melbourne University School of Population and Global Health from 2001 to 2019.

Prof. Nolan is a paediatrician and clinical epidemiologist. He graduated in medicine and medical science from the University of Western Australia, trained in paediatrics at the Royal Children's Hospital in Melbourne and the Montréal Children's Hospital, and earned a PhD in epidemiology and biostatistics from McGill University in Montréal.

Jerome Kim 

Dr Jerome Kim is Director General of the International Vaccine Institute (IVI) and an internationally recognised expert in vaccine evaluation and development. He is also a Distinguished Visiting Professor in the College of Natural Sciences at Seoul National University. Dr Kim has authored more than 300 scientific publications and has played a leading role in advancing vaccines for global health. He graduated from the University of Hawaii with high honours in History and highest honours in Biology and received his M.D. from Yale University School of Medicine.

Cheryl Keech

Dr. Cheryl Keech works to develop solutions for vaccine-preventable diseases by focusing on strategic product development: designing innovative, fit-for-purpose clinical trials and supporting assay development, national/global regulatory interactions, pharmacovigilance, and health technology assessments.  She has led clinical development programs for multiple vaccine platforms across multiple organizations (Pharma, NGO, Biotech, CRO), spanning all major markets, global regions, World Bank economies and development phases (pre- and post-licensure).  She believes that through partnering, strong value propositions can be developed; with the goal of obtaining an optimal benefit-to-risk profile for a potential vaccine. She has a passion for ensuring vaccines provide global health equity.